Asbestos-activated peritoneal macrophages release a factor(s) which inhibits lymphocyte mitogenesis.
Intraperitoneal asbestos injection in mice has previously been reported to elicit an activated macrophage population. In the present study supernatants from such macrophages were tested for their effect on thymocyte mitogenesis in response to concanavalin A; control supernatants were obtained from saline- and latex-elicited macrophages. Supernatants from asbestos-elicited macrophages were significantly inhibitory to thymocyte mitogenesis while saline- and latex-elicited macrophages did not release significant amounts of such activity. Asbestos-activated macrophage supernatants were inhibitory in a dose-dependent way and the activity was not secreted by macrophages from mice which had received asbestos in the long term. The inhibitory activity was partially dialysable. Supernatants prepared by treating macrophages in vitro with a lethal dose of asbestos were not inhibitory suggesting that the inhibitory activity in the supernatants of asbestos-activated macrophages did not leak from dead or dying cells. The asbestos macrophage supernatant was also significantly inhibitory to mature T-cell-enriched spleen cells but had no effect on fibroblasts, suggesting that the inhibitory effect could be lymphoid cell specific.
D000818:Animals; D001194:Asbestos / Q000008:administration & dosage / Q000276:immunology*; D001202:Ascitic Fluid / Q000276:immunology; D003208:Concanavalin A / Q000494:pharmacology; D007274:Injections, Intraperitoneal; D008213:Lymphocyte Activation; D008262:Macrophage Activation; D051379:Mice; D008808:Mice, Inbred CBA
D003208:Concanavalin A; D001194:Asbestos